Related Experiment Video
Updated: Aug 8, 2025

Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
Efficient generation and characterization of chimeric dengue viral-like particles
N Veena Rani1, Neera Kapoor1, Anuja Krishnan2
1School of Sciences, IGNOU, New Delhi, 110068, India.
Researchers engineered Dengue virus (DENV) virus-like particles (VLPs) using Vesicular Stomatitis virus (VSV) components. These enhanced DENV VLPs show improved production and retain key antigenic and functional properties for potential vaccine and diagnostic applications.
Area of Science:
- Virology
- Biotechnology
- Immunology
Background:
- Viral-like particles (VLPs) are valuable tools in diagnostics, drug delivery, and vaccine development due to their non-infectious and immunogenic nature.
- Dengue virus (DENV) is inefficient in VLP production, limiting its application.
- Vesicular Stomatitis virus (VSV) G protein's stem and transmembrane regions are known to facilitate VLP budding.
Purpose of the Study:
- To enhance Dengue virus (DENV) virus-like particle (VLP) production by creating chimeric VLPs.
- To assess the immunogenicity and functional properties of these novel chimeric DENV VLPs.
Main Methods:
- Generated chimeric DENV-2 VLPs by replacing E protein regions with corresponding VSV G protein regions (STEM or TM).
- Quantified VLP secretion levels and cellular expression.
- Evaluated VLP recognition by monoclonal antibody 4G2 and interaction with patient sera.
- Assessed heparin-binding affinity and cell-cell fusion activity.
Main Results:
- Chimeric VLPs were secreted at 2-4 fold higher levels than wild-type DENV VLPs.
- Antigenic determinants were preserved, as shown by recognition with antibody 4G2 and patient sera.
- Chimeric VLPs retained heparin-binding affinity, indicating preserved function.
- Cell-cell fusion activity did not significantly increase in chimeras compared to wild-type DENV.
Conclusions:
- Chimeric Dengue virus (DENV) virus-like particles (VLPs) demonstrate significantly improved production efficiency.
- These enhanced VLPs maintain crucial antigenic and functional characteristics.
- The study suggests chimeric DENV VLPs hold promise for vaccine production and serodiagnosis applications.
More Related Videos
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
08:40Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019